• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

佩罗尼氏病问卷(PDQ):西班牙语翻译及验证。

Peyronie's Disease Questionnaire (PDQ): Spanish translation and validation.

机构信息

Urology Department, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.

Lyx Instituto de Urología, Universidad Francisco de Vitoria, Madrid, Spain.

出版信息

Int J Impot Res. 2022 Aug;34(5):501-504. doi: 10.1038/s41443-021-00460-5. Epub 2021 Jul 19.

DOI:10.1038/s41443-021-00460-5
PMID:34282285
Abstract

The Peyronie's Disease Questionnaire (PDQ) is a 15-question self-reported questionnaire that evaluates the severity and physical and psychosexual issues of Peyronie's disease (PD) symptoms in three scales: "psychological and physical symptoms," "penile pain," and "symptom bother." Previous studies validated the PDQ US version and confirmed its test-retest reliability and responsiveness. The aim is to translate and validate the Spanish version of the PDQ to be used in the clinical practice and in PD research studies in Spain. A non-interventional, observational study with 160 PD patients was conducted. Patients included from four healthcare centers in Spain and completed the PDQ in two study visits separated for a period of 4-7 days from March 2018 to June 2019. Patients received no type of treatment or intervention. Different statistical tests were applied to the data in order to validate the structural and construct of the PDQ, as well as its internal reliability, temporal stability reliability, reliability between observers, and test-retest reliability. Cronbach's alpha over 0.9 showed good internal consistency. We found an ICC agreement of 0.82 (test-retest) for the three scales of the Spanish version of the PDQ, which demonstrates good reliability. When comparing Visit 1 and Visit 2 questionnaires mean scores, the PDQ showed non-significant differences, as expected because no intervention or treatment was administered to the patients between visits. Translation and validation of the PDQ for the Spanish population makes available a valid, useful, and reliable tool to properly evaluate quality of life of men suffering PD.

摘要

《勃起功能障碍问卷》(PDQ)是一个包含 15 个问题的自我报告问卷,它从三个方面评估了勃起功能障碍(PD)症状的严重程度以及身体和心理性问题:“心理和身体症状”、“阴茎疼痛”和“症状困扰”。先前的研究已经验证了 PDQ 美国版本的有效性,并确认了其重测信度和反应度。本研究旨在翻译和验证 PDQ 的西班牙语版本,以便在西班牙的临床实践和 PD 研究中使用。一项非干预性、观察性研究纳入了 160 名 PD 患者。患者来自西班牙的四家医疗中心,在 2018 年 3 月至 2019 年 6 月期间,在为期 4-7 天的两次研究就诊中完成了 PDQ。患者未接受任何类型的治疗或干预。为了验证 PDQ 的结构和构建,以及其内部可靠性、时间稳定性可靠性、观察者之间的可靠性和重测信度,应用了不同的统计检验。Cronbach's alpha 大于 0.9 表明具有良好的内部一致性。我们发现,西班牙语版 PDQ 的三个分量表的 ICC 一致性为 0.82(重测),这表明可靠性良好。当比较第一次就诊和第二次就诊的问卷平均得分时,PDQ 显示出无显著差异,这是意料之中的,因为在两次就诊之间没有向患者提供干预或治疗。PDQ 的西班牙语版本的翻译和验证为评估患有 PD 的男性的生活质量提供了一个有效、有用且可靠的工具。

相似文献

1
Peyronie's Disease Questionnaire (PDQ): Spanish translation and validation.佩罗尼氏病问卷(PDQ):西班牙语翻译及验证。
Int J Impot Res. 2022 Aug;34(5):501-504. doi: 10.1038/s41443-021-00460-5. Epub 2021 Jul 19.
2
The test-retest reliability of the Peyronie's disease questionnaire.佩罗尼氏病问卷的重测信度。
J Sex Med. 2015 Feb;12(2):543-8. doi: 10.1111/jsm.12769. Epub 2014 Nov 17.
3
Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire.与 Peyronie 病相关的困扰和苦恼:Peyronie 病问卷的验证。
J Urol. 2013 Aug;190(2):627-34. doi: 10.1016/j.juro.2013.01.090. Epub 2013 Jan 31.
4
Validation of the Italian version of the Peyronie's Disease Questionnaire (PDQ).验证《佩罗尼氏病问卷》(PDQ)的意大利文版本。
Int J Impot Res. 2024 Sep;36(6):588-591. doi: 10.1038/s41443-023-00792-4. Epub 2023 Nov 17.
5
Self-report and Clinical Response to Peyronie's Disease Treatment: Peyronie's Disease Questionnaire Results From 2 Large Double-Blind, Randomized, Placebo-Controlled Phase 3 Studies.佩罗尼氏病治疗的自我报告与临床反应:两项大型双盲、随机、安慰剂对照3期研究的佩罗尼氏病问卷调查结果
Urology. 2015 Aug;86(2):291-8. doi: 10.1016/j.urology.2015.04.047. Epub 2015 Jul 18.
6
Responsiveness of the Peyronie's Disease Questionnaire (PDQ).佩罗尼氏病问卷(PDQ)的反应性。
J Sex Med. 2015 Apr;12(4):1072-9. doi: 10.1111/jsm.12838. Epub 2015 Feb 9.
7
The symptomatic burden of Peyronie's disease at presentation according to patient age: A critical analysis of the Peyronie's disease questionnaire (PDQ) domains.根据患者年龄分析就诊时的勃起功能障碍症状负担:勃起功能障碍问卷(PDQ)各领域的批判性分析。
Andrology. 2023 Mar;11(3):501-507. doi: 10.1111/andr.13352. Epub 2022 Dec 5.
8
Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.西地那非 25 毫克口腔崩解片+胶原酶梭菌组织溶解酶与单独使用胶原酶梭菌组织溶解酶治疗阴茎硬结症的比较:配对比较分析。
J Sex Med. 2018 Oct;15(10):1472-1477. doi: 10.1016/j.jsxm.2018.08.012. Epub 2018 Sep 20.
9
Evaluating the Impact of Penile Girth Discrepancy on Patient Bother in Men With Peyronie's Disease: An Observational Study.评估阴茎周径差异对患有 Peyronie 病男性患者困扰的影响:一项观察性研究。
J Sex Med. 2020 Aug;17(8):1560-1565. doi: 10.1016/j.jsxm.2020.05.003. Epub 2020 Jun 20.
10
Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease.正在进行的 3 期临床试验中,关于胶原酶组织溶菌素治疗佩罗尼病患者的基线特征。
J Sex Med. 2013 Nov;10(11):2822-31. doi: 10.1111/jsm.12312. Epub 2013 Sep 24.

引用本文的文献

1
The Role of the Peyronie's Disease Questionnaire in Translation, Cultural Adaptation, and Treatment Management for Portuguese-Speaking Populations.佩罗尼氏病问卷在葡萄牙语人群的翻译、文化调适及治疗管理中的作用。
Cureus. 2024 Dec 23;16(12):e76242. doi: 10.7759/cureus.76242. eCollection 2024 Dec.

本文引用的文献

1
Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study.阴茎牵引疗法结合新型装置“Penimaster PRO”在稳定期的 Peyronie 病中有效且安全:一项对照多中心研究。
BJU Int. 2019 Apr;123(4):694-702. doi: 10.1111/bju.14602. Epub 2018 Nov 22.
2
The relationship between penile deformity, age, psychological bother, and erectile dysfunction in a sample of men with Peyronie's Disease (PD).佩罗尼氏病(PD)男性样本中阴茎畸形、年龄、心理困扰和勃起功能障碍之间的关系。
Int J Impot Res. 2018 Aug;30(4):171-178. doi: 10.1038/s41443-018-0029-3. Epub 2018 May 25.
3
Responsiveness of the Peyronie's Disease Questionnaire (PDQ).
佩罗尼氏病问卷(PDQ)的反应性。
J Sex Med. 2015 Apr;12(4):1072-9. doi: 10.1111/jsm.12838. Epub 2015 Feb 9.
4
The test-retest reliability of the Peyronie's disease questionnaire.佩罗尼氏病问卷的重测信度。
J Sex Med. 2015 Feb;12(2):543-8. doi: 10.1111/jsm.12769. Epub 2014 Nov 17.
5
Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire.与 Peyronie 病相关的困扰和苦恼:Peyronie 病问卷的验证。
J Urol. 2013 Aug;190(2):627-34. doi: 10.1016/j.juro.2013.01.090. Epub 2013 Jan 31.
6
Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.在 2 项大型、双盲、随机、安慰剂对照的 3 期研究中评估胶原酶注射治疗 Peyronie 病的临床疗效、安全性和耐受性。
J Urol. 2013 Jul;190(1):199-207. doi: 10.1016/j.juro.2013.01.087. Epub 2013 Jan 31.
7
The management of Peyronie's disease: evidence-based 2010 guidelines.《佩罗尼氏病的治疗管理:基于循证的 2010 年指南》。
J Sex Med. 2010 Jul;7(7):2359-74. doi: 10.1111/j.1743-6109.2010.01850.x. Epub 2010 May 19.
8
Risk factors for emotional and relationship problems in Peyronie's disease.佩罗尼氏病中情绪和人际关系问题的风险因素。
J Sex Med. 2008 Sep;5(9):2179-84. doi: 10.1111/j.1743-6109.2008.00949.x. Epub 2008 Jul 14.
9
The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction.患有勃起功能障碍的糖尿病患者中佩罗尼氏病的患病率。
Int J Impot Res. 2007 Mar-Apr;19(2):213-7. doi: 10.1038/sj.ijir.3901518. Epub 2006 Aug 17.
10
Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil.巴西南部50岁以上男性佩罗尼氏病的患病率。
Int J Impot Res. 2001 Oct;13(5):291-3. doi: 10.1038/sj.ijir.3900727.